M4MM

Compass Pathways Advances Psilocybin Research in the UK

LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...

Ohio’s Cannabis Market Expansion in 2024

LOS ANGELES- In 2024, Ohio's legal cannabis market achieved sales exceeding $675 million, marking a 40% increase from the previous year's $484 million. This growth is attributed to the commencement of adult-use cannabis sales in ...

Subscribe To Our Newsletter